PRETREATMENT WITH COMBINATION CHEMOTHERAPY FOLLOWED BY ALLOGENIC BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH A LOW RELAPSE RATE IN YOUNG-PATIENTS WITH ADVANCED MYELODYSPLASIA
J. Cermak et al., PRETREATMENT WITH COMBINATION CHEMOTHERAPY FOLLOWED BY ALLOGENIC BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH A LOW RELAPSE RATE IN YOUNG-PATIENTS WITH ADVANCED MYELODYSPLASIA, Blood, 90(10), 1997, pp. 4485-4485